Related Experiment Video
Updated: Jun 24, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
DAB2IP inhibits glucose uptake by modulating HIF-1α ubiquitination under hypoxia in breast cancer
Hongliang Dong1,2, Weiyi Jia1,2,3, Weijian Meng1,2
1Department of GI Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Abstract:
Metabolic reprogramming has become increasingly important in tumor biology research. The glucose metabolic pathway is a major energy source and is often dysregulated in breast cancer. DAB2IP is widely reported to be a tumor suppressor that acts as a scaffold protein to suppress tumor malignancy in breast cancer. Interestingly, DAB2IP has also been found to be a potential regulator of glucose uptake; however, the exact mechanism remains unclear. In this study, we found that DAB2IP inhibited glucose uptake under hypoxia conditions in breast cancer cells by suppressing HIF-1α signals. Mechanically, DAB2IP interacted with the E3 ubiquitin ligase STUB1 via its PER domain, thus triggering STUB1 mediated HIF-1α ubiquitylation and degradation, and inhibit glucose metabolism and tumor progression. Deleting the PER domain abrogated the DAB2IP-related inhibitory effects on glucose uptake, intracellular ATP production, and lactic acid production in breast cancer cells. These findings elucidate the biological roles of DAB2IP in cancer-related glucose metabolism as well as a novel mechanism by which STUB1-driven HIF-1α ubiquitylated degradation is regulated in breast cancer.
Insights
DAB2IP suppresses glucose uptake in breast cancer by inhibiting HIF-1α signaling. It achieves this by interacting with STUB1, leading to HIF-1α degradation and reduced tumor progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Metabolic reprogramming is crucial in tumor biology, with glucose metabolism frequently altered in breast cancer.
- DAB2IP is a known tumor suppressor in breast cancer, but its role in regulating glucose uptake is not fully understood.
Purpose of the Study:
- To investigate the mechanism by which DAB2IP regulates glucose uptake in breast cancer cells.
- To elucidate the role of DAB2IP in hypoxia-driven metabolic changes and tumor progression.
Main Methods:
- Investigated DAB2IP's effect on glucose uptake in breast cancer cells under hypoxia.
- Utilized co-immunoprecipitation to study protein interactions between DAB2IP, STUB1, and HIF-1α.
- Assessed HIF-1α ubiquitylation and degradation.
- Examined the impact of DAB2IP's PER domain deletion on cellular metabolism.
Main Results:
- DAB2IP inhibited glucose uptake in breast cancer cells under hypoxia by suppressing HIF-1α signaling.
- DAB2IP interacted with STUB1 via its PER domain, promoting HIF-1α ubiquitylation and degradation.
- Deletion of the PER domain abolished DAB2IP's inhibitory effects on glucose uptake, ATP, and lactic acid production.
Conclusions:
- DAB2IP plays a significant role in regulating cancer-related glucose metabolism.
- A novel mechanism involving STUB1-mediated HIF-1α degradation regulated by DAB2IP was identified in breast cancer.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Inhibition of Cdk Activity
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cell Specific Gene Expression
Abnormal Proliferation

